Product Highlight - Levetiracetam (Julitam I.V.)

27 Feb 2024
Product Highlight - Levetiracetam (Julitam I.V.)

Levetiracetam (Julitam I.V.) is used as an alternative for patients when oral administration is temporarily not feasible:

  • as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalization in adults and children from 4 years of age.1
  • in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.1
  • in the treatment of primary generalized tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalized Epilepsy.1
  • as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patients from 16 years of age.1

 

REFERENCE:
1. Julitam IV Product Monograph.


Zydus Healthcare Philippines, Inc.
Unit 903-904, 9th Floor, Eco Tower,
32nd Street corner 9th Avenue,
Bonifacio Global City, Taguig City 1634
Tel No: (+63-2) 8815 1124

Related MIMS Drugs